Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

ress in advancing programs within its late-stage development pipeline. These programs have significant potential to drive the company's growth beyond 2011.

Mozobil(TM) (plerixafor) for stem-cell transplantation

-- Genzyme plans to file mid year for U.S. and European approval for

Mozobil's use in treating patients with multiple myeloma and patients

with lymphoma. The company expects to launch the product in the United

States early next year upon approval and to rapidly expand the

product's availability around the world. The company anticipates peak

annual sales of the product in the transplant setting of $400 million.

Mozobil is an innovative product intended to enhance the mobilization

of stem cells for transplantation in patients with lymphoma and

multiple myeloma. In two pivotal clinical studies, Mozobil showed the

ability to quickly and predictably prepare cancer patients for a

transplant to treat their disease. Genzyme is also exploring

additional indications for Mozobil, including its potential use in

chemosensitization procedures.

Clolar for adult AML

-- Clolar is approved in the United States and Europe for the treatment of

acute lymphoblastic leukemia in relapsed and refractory pediatric

patients. Genzyme is developing the product for use globally as a

first-line therapy for the treatment of adult acute myeloid leukemia

(AML) and myelodysplastic syndromes, significantly larger indications

that the company estimates will drive peak annual sales of the product

to approximately $600 million. The company intends to submit a

supplemental new drug application in the United States later this year

to include an adult AML indication. This application will be based on

results from the CLASSIC II clinical trial involving older adult AML

<
'/>"/>
SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, ... human body part. Similar to the liver, or heart, the ... repair and grow. Recent reports from the mankatofreepress.com explained how ... as important as other life supporting organs. The article suggests ... cell reproduction, increase the appearance of skin, and fight off ...
(Date:6/18/2013)... Nasseo, Inc. today announces that it ... of hundreds of applicants by the Arizona Commerce ... Challenge . The Arizona Innovation Challenge (AIC) awards the ... challenge, granting a financial award to what it deems ... state of the art dental and orthopedic implant surface ...
(Date:6/18/2013)... June 18, 2013 The ... of the HELM biomolecular representation standard software toolkit ... licence. HELM (Hierarchical Editing Language for ... of biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) ... sequence-based informatics methodologies impractical or unusable. HELM solves ...
(Date:6/18/2013)... LONDON , June 18, 2013 /PRNewswire/ ... leading international investment research firm, announces the ... (BIO.PA), a French biopharmaceutical company developing and ... supportive care indications.      (Logo: ... a comprehensive report examining the investment merits ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... , ... for spaces leased to biotech, pharma and medical devices tenants are faring better in some ... ... the recession, the credit crunch, pharmaceuticals industry mergers and an overall slump in the commercial ...
... MUMBAI, July 24 , ... Annual Executive,MindXchange on Biotechnology Applications in the Food & Beverage ... food processing industry has seen some spectacular product,developments such as ... A lot more has to be achieved through cutting,edge R&D ...
... Open Monoclonal Technology, Inc. (OMT), in collaboration with ... The Medical College of Wisconsin, and INSERM, today announced ... detailed in "Knockout Rats Produced via Embryo Microinjection of ... issue of Science . The creation of ...
Cached Biology Technology:Life Sciences Real Estate Outperforming Other Sectors 2Life Sciences Real Estate Outperforming Other Sectors 3Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan 2Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan 3Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan 4OMT announces a breakthrough in the development of a novel human antibody platform 2
(Date:6/17/2013)... Research Foundation and Horizon Pharma further establish their commitment ... 2013 AGA-Horizon Pharma Fellow Abstract Prizes and the 2013 ... year, this competition continues to grow in popularity among ... basic and clinical research," said Nicholas F. LaRusso, MD, ... extremely proud of all that these fellows and students ...
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... (June 16, 2013)Male mice who were fed a high-fat ... offspring who also had higher levels of body fat, ... was observed primarily in male offspring, despite their consumption ... annual meeting of The Endocrine Society in San Francisco, ... may affect metabolism and behavior of offspring dependent on ...
Breaking Biology News(10 mins):Horizon Pharma Abstract Prizes recognize promising fellows and students 2Obese male mice father offspring with higher levels of body fat 2
... making a sentence sound like a question? But actually, being ... may be a sign of superior empathy? A new study ... the same brain regions to produce and understand intonation in speech. ... mirror neurons. This study shows for the first time that prosody ...
... Nanyang Technological University (NTU) and Rice University ... agreed to jointly establish the Institute of Sustainable ... the multidisciplinary bi-national institute will create new science ... systems and other radical new information technologies that ...
... and respond to electric fields is the aim of ... to Min Zhao, professor of dermatology and ophthalmology at ... Living cells are already known to respond to ... light, temperature and chemical signals. Understanding this mechanism would ...
Cached Biology News:Music in speech equals empathy in heart? 2NTU, Rice establish infodynamics institute 2NTU, Rice establish infodynamics institute 3
... The kit for stabilizing 50g of purified ... StabMRT Plus Kit delivers all of the advantages ... but in addition the RNA can be used ... , This product has been optimised for the ...
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
Biology Products: